• About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
Menu
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
  • Join PW
Click Here To Share Your Story With Gastric/GEJ Cancer
Click Here to Read Real Patient & Caregiver Stories
Click Here To Learn More

clinical trial

  1. Home>
  2. clinical trial>
  3. Page 28
Using AI to Further ADNP Syndrome Research
PublicDomainPictures / Pixabay

Using AI to Further ADNP Syndrome Research

  • Post author:Jessica Lynn
  • Post published:May 15, 2020
  • Post category:ADNP Syndrome/Rare Disease

It all began with an email in 2019. Matt Might, director of the Hugh Kaul Precision Medicine Institute, shot his thoughts over to neurosurgery resident Matt Davis, whose 3-year-old son…

Continue Reading Using AI to Further ADNP Syndrome Research
Why Getting Funding for Rare Disease Clinical Trials is so Difficult
source: pixabay.com

Why Getting Funding for Rare Disease Clinical Trials is so Difficult

  • Post author:Trudy Horsting
  • Post published:March 5, 2020
  • Post category:Rare Disease

Why are rare diseases so difficult to study? Is it just their rarity? Or is it also industry challenges?  Unfortunately, industry has a lot to do with it. Clinical Trial…

Continue Reading Why Getting Funding for Rare Disease Clinical Trials is so Difficult
New PH1 Treatment Clears Phase 3 Study
source: pixabay.com

New PH1 Treatment Clears Phase 3 Study

  • Post author:Jean Martell
  • Post published:December 18, 2019
  • Post category:Primary Hyperoxaluria Type 1

Big development for those in the primary hyperoxaluria type 1 (PH1) community! Alnylam Pharmaceuticals just announced that its Phase 3 study of lumasiran, an investigational therapy for the treatment of primary…

Continue Reading New PH1 Treatment Clears Phase 3 Study
Potential Congenital Adrenal Hyperplasia Drug Treatment Clears Hurdle

Potential Congenital Adrenal Hyperplasia Drug Treatment Clears Hurdle

  • Post author:Jean Martell
  • Post published:September 20, 2019
  • Post category:Congenital Adrenal Hyperplasia

Some promising news for the congenital adrenal hyperplasia (CAH) community! Spruce Biosciences is one step closer to a treatment for CAH after new phase 2a data showed the drug reduced…

Continue Reading Potential Congenital Adrenal Hyperplasia Drug Treatment Clears Hurdle
New Clinical Trial for Eosinophilic Esophagitis is Now Recruiting Participants

New Clinical Trial for Eosinophilic Esophagitis is Now Recruiting Participants

  • Post author:Trudy Horsting
  • Post published:June 24, 2019
  • Post category:Eosinophilic Esophagitis

Eosinophilic Esophagitis (EoE) Eosinophilic esophagitis (EoE) is a rare and chronic disorder which affects the digestive system. Eosinophils are a type of white blood cell that help fight infections. This…

Continue Reading New Clinical Trial for Eosinophilic Esophagitis is Now Recruiting Participants
Graft Versus Host Disease Drug Candidate Completes Phase IIa Trial

Graft Versus Host Disease Drug Candidate Completes Phase IIa Trial

  • Post author:Scott Carlson
  • Post published:January 28, 2019
  • Post category:Graft versus Host Disease

According to a publication from BusinessWire, the Maryland-based pharmaceutical company OncoImmune, Inc. has announced successful phase 2 trial results for its acute graft versus host disease (GVHD) drug CD24Fc. Graft…

Continue Reading Graft Versus Host Disease Drug Candidate Completes Phase IIa Trial
Sutimlimab Moves to Phase 3 Trials: A New Potential Therapy for Cold Agglutinin Disease!

Sutimlimab Moves to Phase 3 Trials: A New Potential Therapy for Cold Agglutinin Disease!

  • Post author:Trudy Horsting
  • Post published:December 31, 2018
  • Post category:Cold Agglutinin Disease/Rare Disease

Cold agglutinin disease (CAD) occurs when the body's antibodies destroy their own red blood cells. It is a form of hemolytic anemia, meaning the body can't produce enough blood cells fast…

Continue Reading Sutimlimab Moves to Phase 3 Trials: A New Potential Therapy for Cold Agglutinin Disease!
New Phase 3 Trial for Prader-Willi Syndrome is now Enrolling Patients
Source: Pixabay.com

New Phase 3 Trial for Prader-Willi Syndrome is now Enrolling Patients

  • Post author:Trudy Horsting
  • Post published:December 20, 2018
  • Post category:Prader-Willi Syndrome

Prader-Willi syndrome (PWS) is a neurodevelopmental disorder which causes intellectual disability, a deficiency of growth hormones, compulsive behavior, a high risk of obesity, and hyperphagia, a symptom which can be…

Continue Reading New Phase 3 Trial for Prader-Willi Syndrome is now Enrolling Patients
New Study Shows Significant Efficacy in Treating Hereditary Angioedema
guvo59 / Pixabay

New Study Shows Significant Efficacy in Treating Hereditary Angioedema

  • Post author:Jean Martell
  • Post published:November 30, 2018
  • Post category:Rare Disease

There's some good news for the hereditary angioedema patient community this week! Shire, a global biotechnology company focused on rare diseases, announced in the Journal of the American Medical Association (JAMA) publication…

Continue Reading New Study Shows Significant Efficacy in Treating Hereditary Angioedema
New Short Bowel Syndrome Treatment Enters Phase 3 Trial

New Short Bowel Syndrome Treatment Enters Phase 3 Trial

  • Post author:Samuel Sachs
  • Post published:October 15, 2018
  • Post category:Short bowel syndrome

Zealand Pharma A/S (Zealand) recently announced in a press release the start phase 3 trial for short bowel syndrome treatment. The trial investigates the use of glepaglutide as a treatment…

Continue Reading New Short Bowel Syndrome Treatment Enters Phase 3 Trial
ICYMI: University of Alabama Receives Multiyear Grant for IPF Research

ICYMI: University of Alabama Receives Multiyear Grant for IPF Research

  • Post author:Samuel Sachs
  • Post published:September 1, 2018
  • Post category:Idiopathic Pulmonary Fibrosis

A report on newsmedical.net details a major grant awarded for the research of idiopathic pulmonary fibrosis (IPF). The grant totals $8.9 million, aiming to fund a program for several years.…

Continue Reading ICYMI: University of Alabama Receives Multiyear Grant for IPF Research
What Mitochondrial Disease Patients Say Matters About Clinical Trials
Source: Pixabay

What Mitochondrial Disease Patients Say Matters About Clinical Trials

  • Post author:Samuel Sachs
  • Post published:June 11, 2018
  • Post category:Mitochondrial Disease

A new clinical trial aims to be the first treatment for mitochondrial disease to be granted FDA approval. Whether or not the trial results in a landmark treatment, it is…

Continue Reading What Mitochondrial Disease Patients Say Matters About Clinical Trials
Pfizer Announces Success of Transthyretin Cardiomyopathy Drug
Source: Pixabay

Pfizer Announces Success of Transthyretin Cardiomyopathy Drug

  • Post author:Samuel Sachs
  • Post published:April 10, 2018
  • Post category:Amyloidosis

Major pharmaceutical company Pfizer recently announced the success of a new experimental product. The drug targets a disease called transthyretin cardiomyopathy, related to amyloidosis, a rare and dangerous disease that affects…

Continue Reading Pfizer Announces Success of Transthyretin Cardiomyopathy Drug
A New Treatment for Glioblastoma Enters Phase Three Trials
Source: Pixabay

A New Treatment for Glioblastoma Enters Phase Three Trials

  • Post author:Samuel Sachs
  • Post published:January 25, 2018
  • Post category:Brain Cancer/Glioblastoma

A phase three clinical study is beginning for a new glioblastoma treatment. The new drug is called VAL-083 and is specially designed for treatment of late-stage glioblastoma. The study will…

Continue Reading A New Treatment for Glioblastoma Enters Phase Three Trials
If Your Baby Has Bile Acid Synthesis Disorder, ChiLDReN is There to Help
geralt / Pixabay

If Your Baby Has Bile Acid Synthesis Disorder, ChiLDReN is There to Help

  • Post author:Minden Cantrell
  • Post published:November 7, 2017
  • Post category:Bile Acid Synthesis Disorders/Rare Disease

As parents, we want to protect our children from harm and keep them safe. So when your child is suffering from a rare metabolic disorder, it's natural to feel helpless.…

Continue Reading If Your Baby Has Bile Acid Synthesis Disorder, ChiLDReN is There to Help
Rare Disease Drug’s Exorbitant Cost Renews Debate on Pharma Pricing Ethics
Source: Pixabay

Rare Disease Drug’s Exorbitant Cost Renews Debate on Pharma Pricing Ethics

  • Post author:Jean Martell
  • Post published:November 3, 2017
  • Post category:Rare Disease/Spinal Muscular Atrophy

A Futurism article this week put into very human terms the ongoing question we face when it comes to rare disease treatment and Pharma: What is the cost of life?…

Continue Reading Rare Disease Drug’s Exorbitant Cost Renews Debate on Pharma Pricing Ethics
New Drug for Short Bowel Syndrome Gets Orphan Designation
kkolosov / Pixabay

New Drug for Short Bowel Syndrome Gets Orphan Designation

  • Post author:Jean Martell
  • Post published:October 27, 2017
  • Post category:Rare Disease/Short bowel syndrome

The FDA this week granted orphan drug designation to glepaglutide for the treatment of short bowel syndrome (SBS), developed by Zealand Pharma A/S. SBS is a rare disorder where an…

Continue Reading New Drug for Short Bowel Syndrome Gets Orphan Designation
Children’s Health Doctors Get to the Bottom of Girl’s Neuroblastoma
Source: Pixabay

Children’s Health Doctors Get to the Bottom of Girl’s Neuroblastoma

  • Post author:Andres Rovira
  • Post published:October 17, 2017
  • Post category:Neuroblastoma

At first glance, little Victoria Thompson looks like your average happy and healthy toddler. You'd have no idea that once upon a time, she had a tumor on her kidney…

Continue Reading Children’s Health Doctors Get to the Bottom of Girl’s Neuroblastoma
A New Hope for Rare Bone Disease
Source: Pixabay

A New Hope for Rare Bone Disease

  • Post author:Andres Rovira
  • Post published:September 28, 2017
  • Post category:Hereditary Multiple Osteochondromas/Rare Disease

It's called Hereditary multiple exostoses (HME). Yes, quite the mouthful. Our friendly neighborhood scientists at Children's Hospital of Philly (CHOP) have been working diligently to study this rare bone disease…

Continue Reading A New Hope for Rare Bone Disease
Multiple Myeloma May Have a New Warrior Soon
Source: www.pixabay.com

Multiple Myeloma May Have a New Warrior Soon

  • Post author:Al Pendleton
  • Post published:August 31, 2017
  • Post category:Multiple Myeloma/Rare Disease

Cancer treatment, much like golf, is all about the follow-through. It is true that chemotherapy and surgery are important. However, it’s the maintenance therapies that keep people living for years…

Continue Reading Multiple Myeloma May Have a New Warrior Soon
Gene Therapy May Become Standard of Care for Multiple Myeloma
Source: www.pixabay.com

Gene Therapy May Become Standard of Care for Multiple Myeloma

  • Post author:Al Pendleton
  • Post published:August 28, 2017
  • Post category:Multiple Myeloma/Rare Disease

Cancer. This word can inspire fear in even the most stalwart of individuals. How many other diseases are known by a phrase involving just the first letter? The Big C.…

Continue Reading Gene Therapy May Become Standard of Care for Multiple Myeloma
Clinical Trials of Micronutrient for ALS on the Horizon
Source: Pixabay

Clinical Trials of Micronutrient for ALS on the Horizon

  • Post author:Al Pendleton
  • Post published:August 15, 2017
  • Post category:Amyotrophic Lateral Sclerosis

All you have to do is look around. If you do, you’ll see the rate of progress accelerating. Look at anything modern. Some people liken this to Moore’s Law concerning…

Continue Reading Clinical Trials of Micronutrient for ALS on the Horizon
Revolutionary CF Treatment Already Approved for Another Disease
Source: www.pixabay.com

Revolutionary CF Treatment Already Approved for Another Disease

  • Post author:Al Pendleton
  • Post published:August 10, 2017
  • Post category:Cystic Fibrosis/Rare Disease

Most things have multiple functions. The tire iron you use to jack up the car when changing a flat tire? It can be used as a self-defense weapon if an…

Continue Reading Revolutionary CF Treatment Already Approved for Another Disease
Altering Stem Cells Could Point the Way to a Fabry-Free Future
[Source: pixabay.com]

Altering Stem Cells Could Point the Way to a Fabry-Free Future

  • Post author:Ronald Ledsen
  • Post published:August 4, 2017
  • Post category:Fabry Disease/Rare Disease

If you’re a science nerd, we live in some pretty exciting times. Even though we’re going through a moment where it feels like science and empirical evidence itself is under…

Continue Reading Altering Stem Cells Could Point the Way to a Fabry-Free Future
Will This Sickle Cell Research Help Cure ADA SCID?
Source: Pixabay

Will This Sickle Cell Research Help Cure ADA SCID?

  • Post author:Al Pendleton
  • Post published:August 2, 2017
  • Post category:Adenosine Deaminase Deficiency /SCID/Sickle cell anemia

At some point in the past, we decided that it would be important to divide things up when we study them in school. For a long time, all science was…

Continue Reading Will This Sickle Cell Research Help Cure ADA SCID?
  • Go to the previous page
  • 1
  • …
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • Go to the next page
The Mentor She Wished She Had - How Elizabeth Became a Lifeline for EB
Finding Strength Together: Scott and Katie’s Journey with Advanced Kidney
You Are Not Alone: Empowering the Advanced Kidney Cancer Community
Finding Light Through Story-The Power of Ambassadorship in the Endometrial Cancer Community
We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.
Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Partner With Us
Submit a Story

Keep Up to Date

Subscribe to Our Newsletter
Check Out Rare Events
Get Inspired By Our Memes

Learn More

About Us
Rare Diseases and Conditions
Terms of Use
Privacy Notice
Privacy Policy for CA Residents
EU/UK Privacy Notice
Data Privacy Framework: Consumer Privacy Policy
Consumer Health Data Privacy Policy
Cookie Notice

Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope

© Copyright 2024 Patient Worthy

Sign Up With a Patient Worthy Account and Share Your Rare Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info

We're Happy You're Here!

What best describes you when it comes to rare disease? (check all that apply)

What rare disease(s)/conditions are most important to you?

Visit Home Page or

Thank you for signing up for a Patient Worthy Account!

Have a rare disease story to share? Let us know

Share Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info